Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
84,587
Employees84,587
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
84,587
Employees84,587

SNY Key Statistics

Market cap
126.04B
Market cap126.04B
Price-Earnings ratio
12.58
Price-Earnings ratio12.58
Dividend yield
3.16%
Dividend yield3.16%
Average volume
2.26M
Average volume2.26M
High today
$51.60
High today$51.60
Low today
$51.11
Low today$51.11
Open price
$51.18
Open price$51.18
Volume
1.00M
Volume1.00M
52 Week high
$60.12
52 Week high$60.12
52 Week low
$44.73
52 Week low$44.73

SNY News

TipRanks 2h
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment

Regeneron Pharmaceuticals ((REGN)), Sanofi SA ((SNY)), Sanofi ((DE:SNW)), Sanofi ((SNYNF)) announced an update on their ongoing clinical study. Elevate Your In...

TipRanks 2h
Sanofi’s New Vaccine Trial: A Potential Game-Changer for Infant Health

Sanofi SA ((SNY)), Sanofi ((DE:SNW)), Sanofi ((SNYNF)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of...

TipRanks 2h
Sanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer?

Sanofi SA ((SNY)), Sanofi ((DE:SNW)), Sanofi ((SNYNF)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of...

Analyst ratings

76%

of 25 ratings
Buy
76%
Hold
24%
Sell
0%

More SNY News

TipRanks 2d
Sanofi’s Phase 3 Study on Riliprubart for CIDP: A Potential Game-Changer

Sanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of...

TipRanks 2d
Sanofi’s SAR445877 Study: A New Frontier in Cancer Treatment

Sanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.